2,3-Difluoro-1-iodo-4-methylbenzene, 95+%, 50mg

7-Bromo-2-methyl-2H-indazole, 95.0%, 10g

tert-Butyl 1-(Tosyloxy)-3,6,9,12-tetraoxapentadecan-15-oate, >98.0%(HPLC)(T), 500mg

4,5,6,7-Tetrahydro-3-(trifluoromethyl)-1H-pyrazolo[4,3-c]pyridine dihydrochloride, 98%, 100mg

1,2,4-Trifluoro-5-(2,2,2-trifluoroethyl)-benzene, 95.0%, 5g

(E)-1,1,1-Trifluoro-4-phenylbut-3-en-2-ol, 98%, 250mg

(2-Oxo-2,3-dihydrobenzo[d]oxazol-5-yl)boronic acid, 97%, 1g

3,5-Diiodopyridine, 95.0%, 250mg

4-BIPHENYL-3'-CHLORO-ACETIC ACID, 98.0%, 250mg

4-CHLORO-1-TOSYL-1H-INDOLE, 95.0%, 10g

LEXIBULIN, 98%, 10mg

(E)-N-[1-(4-nitrophenyl)ethylidene]hydroxylamine, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-FFAP, 30 m, 0.32 mm, 0.50 µm, 1 Pezzo(i)